AMICUS THERAPEUTICS, INC. Uncategorized Contracts & Agreements
62 Contracts & Agreements
- Second Restated Agreement, dated November 19, 2013 by and between the Registrant and Glaxo Group Limited (Filed With SEC on February 28, 2024)
- Amendment #3 to the Amicus Therapeutics, Inc. Cash Deferral Plan (Filed With SEC on November 9, 2021)
- Description of the Registrant's securities (Filed With SEC on March 2, 2020)
- Amendment #2 to the Amicus Therapeutics, Inc. Cash Deferral Plan (Filed With SEC on December 19, 2019)
- JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on December 21, 2016)
- GOLDMAN, SACHS & CO. | 200 WEST STREET | NEW YORK, NEW YORK 10282-2198 | TEL: 212 ###-###-#### (Filed With SEC on December 21, 2016)
- JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on December 21, 2016)
- GOLDMAN, SACHS & CO. | 200 WEST STREET | NEW YORK, NEW YORK 10282-2198 | TEL: 212 ###-###-#### (Filed With SEC on December 21, 2016)
- AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN (Filed With SEC on October 28, 2016)
- 1 Cedarbrook Drive, Cranbury, NJ 08512 ###-###-#### www.amicusrx.com (Filed With SEC on March 15, 2016)
- AMENDMENT NO. 1 TO THE AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN (Filed With SEC on October 16, 2014)
- LETTER AGREEMENT (Filed With SEC on August 7, 2014)
- LETTER AGREEMENT (Filed With SEC on August 7, 2014)
- AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN (Filed With SEC on July 2, 2014)
- LETTER AGREEMENT (Filed With SEC on May 5, 2014)
- LETTER AGREEMENT (Filed With SEC on May 5, 2014)
- SECOND RESTATED AGREEMENT (Filed With SEC on March 3, 2014)
- LETTER AGREEMENT (Filed With SEC on August 7, 2013)
- LETTER AGREEMENT (Filed With SEC on August 7, 2013)
- LETTER AGREEMENT (Filed With SEC on August 7, 2013)
- 1 Cedar Brook Drive Cranbury, NJ 08512 T: 609 ###-###-#### F: 609 ###-###-#### www.amicusrx.com (Filed With SEC on April 24, 2013)
- 1 Cedar Brook Drive Cranbury, NJ 08512 T: 609 ###-###-#### F: 609 ###-###-#### www.amicusrx.com (Filed With SEC on April 24, 2013)
- 1 Cedar Brook Drive Cranbury, NJ 08512 T: 609 ###-###-#### F: 609 ###-###-#### www.amicusrx.com (Filed With SEC on April 24, 2013)
- /s/ William D. Baird (Filed With SEC on April 16, 2012)
- L E A S E A G R E E M E N T (Filed With SEC on August 16, 2011)
- LETTER AGREEMENT (Filed With SEC on April 18, 2011)
- the progress and results of our clinical trials of our drug candidates, including Amigal (Filed With SEC on March 4, 2011)
- the progress and results of our clinical trials of our drug candidates, including Amigal (Filed With SEC on March 4, 2011)
- the progress and results of our clinical trials of our drug candidates, including Amigal (Filed With SEC on March 4, 2011)
- the progress and results of our clinical trials of our drug candidates, including Amigal (Filed With SEC on March 4, 2011)
- the progress and results of our clinical trials of our drug candidates, including Amigal (Filed With SEC on March 4, 2011)
- AMENDED AND RESTATED AMICUS THERAPEUTICS 2007 DIRECTOR OPTION PLAN (Filed With SEC on June 18, 2010)
- the progress and results of our clinical trials of our drug candidates, including Amigal (Filed With SEC on May 7, 2010)
- Form of (Filed With SEC on February 26, 2010)
- our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on August 6, 2009)
- our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on May 8, 2009)
- our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on February 6, 2009)
- our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on February 6, 2009)
- our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on February 6, 2009)
- our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on February 6, 2009)
